Return to Course LibraryCE InformationPrint Course MaterialsBibliography

Release Date:
May 24, 2016

Expiration Date:
June 1, 2018




Mukesh G. Harisinghani, MD
Professor of Radiology
Harvard Medical School
Director, Abdominal Imaging
Director, Clinical Discovery Program
Massachusetts General Hospital





Equipment Requirements
PC: Win7/Win8, Pentium processor or faster, at least 2GB RAM, Internet Explorer version 10/11, Mozilla FireFox version 33.0.

MAC: OS version 10.8/10.9, Intel processor, at least 2GB RAM, Safari version 6.2, FireFox 33.0


Body Applications of PET/CT:
Not Everything You See is Malignant

A certified one-hour archived webinar for radiologists and advanced radiologic technologists


Recorded on TuesdayMay 10, 2016

This course expires June 1st, 2018

If you want credit, this course must be completed (i.e. view the recording, pass the posttest, AND print the certificate) by no later than May 31st, 2018

Please note, after this course has expired, no aspect of the course will be accessible, including the recorded lecture.

Format: Archived Webinar
Credit: 1.0 AMA PRA Category 1
Credit: 1.0 ARRT Category A+
Tuition:  none

Course Overview
The combination of positron emission tomography (PET) and computed tomography (CT) is increasingly relied upon for evaluating and managing patients with cancer and has demonstrated greater diagnostic accuracy when compared to PET alone.[1] PET/CT imaging combines metabolic function with an anatomic road map to locate and discriminate normal from abnormal tissue.

This case-based lecture will address the benefits and challenges of PET/CT of body imaging and how to distinguish between benign and malignant tissue.

1. Griffeth L. Use of PET/CT scanning in cancer patients: technical and practical considerations. Proc (Bayl Univ Med Cent). 2005;18(4):321-220.

Educational Objectives
After completing this activity, the participant should be better able to:

  • Describe the benefits of body PET/CT for oncologic imaging
  • Discuss how PET/CT imaging is used for patients with suspected or confirmed malignancy
  • Differentiate between benign and malignant tissue on PET/CT images of the body

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. For more information go to

Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A+ continuing education credit.

How to Participate
There are no fees or prerequisites to participate in this program.

  • Click on the blue link. Complete the precourse questions and SUBMIT.
  • Click on the blue link again to view the recording.

How to Receive Credit

  • Log-in to your account at
  • View the entire educational activity session. At the conclusion of the lecture, close the recording window.
  • Return to the course in your account at
  • From the COURSE HOME page, click the button for POSTTEST and for EVALUATION.
  • A passing grade of at least 75% is required to receive credit. You may take the test up to three times.
  • Upon receipt of a passing grade, you will be able to print a certificate of credit from your account at

Mukesh G. Harisinghani, MD

After finishing medical school at Grant Medical College at the University of Bombay, Dr. Harisinghani completed his residency in radiology at Massachusetts General Hospital, where he currently serves as Director of Abdominal Imaging. He also serves as Section Editor for Genitourinary Radiology for the American Journal of Roentgenology (AJR).

His clinical expertise is in MR applications within the abdomen and pelvis. While Dr. Harisinghani’s primary clinical interests are in abdominal and pelvic MR imaging, Dr. Harisinghani has also been involved in the development and application of novel molecular markers for early staging of tumors and evaluating inflammation using magnetic nanoparticles.

Dr. Harisinghani has authored or coauthored over 150 scientific papers and has edited five books in his areas of interest.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

The faculty has reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Mukesh G. Harisinghani, MD, has no disclosures to report.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:                                                            

Trace Hutchison, PharmD
Linda McLean, MS
Samantha Mattiucci, PharmD, CCMEP  
Victoria Phoenix, BS  
Jan Schultz, RN, MSN, CCMEP
Judi Smelker-Mitchek, RN, BSN                         

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

For questions regarding this program, please contact ICPME:
Phone: 607-257-5860 X10

Jointly provided by


This activity is supported by an independent educational grant from GE Healthcare

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.